2
2
6
6
6
6
1
1
4
4
16
16
19
19
14
14
16
16
16
16
2018
2009
Company (102)Hospital (2)University (2)
1 - 10 of 102
Sort by
Patent
Publication NumberAU 2013292330 B2StatusIssued PatentAvailabilityUnknownFiling Date2013-07-19Publication Date2018-07-12
The present disclosure relates to the acceleration of hematopoietic compartment reconstitution in a subject in need of hematopoietic stem cell transplantation by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein in combination with hematopoietic stem cell transplantation and to the enhancement of hematopoietic compartment autoreconstitution in a subject in need thereof by administering a composition having a protein transduction domain-MYC (PTD-MYC)…
Patent
Publication NumberUS 20180177827StatusPatent ApplicationAvailabilityUnknownFiling Date2017-07-06Publication Date2018-06-28
The present disclosure relates to the production of red blood cells from hematopoietic stem cells, by differentiating such cells in the presence of a protein that induces cell survival and proliferation.
Patent
Publication NumberEP 3339321 A1StatusPatent ApplicationAvailabilityUnknownFiling Date2009-08-28Publication Date2018-06-27
Disclosed herein are methods of modulation of the viability of a cell. Further disclosed herein are methods of modulating an immune response. Further disclosed herein are methods of identifying agents capable of modulation of the viability of a cell or an immune response. Further disclosed herein are agents and compositions capable of modulation of the viability of a cell or an immune response.
Patent
Publication NumberUS 20180153939StatusPatent ApplicationAvailabilityUnknownFiling Date2017-12-01Publication Date2018-06-07
This present disclosure relates to methods and compositions comprising biologically active nanoparticle formulations of MYC protein. Provided are methods of making the nanoparticle formulations and methods of using the nanoparticle formulations for treatment.
Patent
Publication NumberWO 2018102678 A1StatusPatent ApplicationAvailabilityUnknownFiling Date2017-12-01Publication Date2018-06-07
This present disclosure relates to methods and compositions comprising biologically active nanoparticle formulations of MYC protein. Provided are methods of making the nanoparticle formulations and methods of using the nanoparticle formulations for treatment.
Patent
Publication NumberUS 20180117089StatusPatent ApplicationAvailabilityUnknownFiling Date2017-10-16Publication Date2018-05-03
The present disclosure relates to the acceleration of hematopoietic compartment reconstitution in a subject in need of hematopoietic stem cell transplantation by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein in combination with hematopoietic stem cell transplantation and to the enhancement of hematopoietic compartment autoreconstitution in a subject in need thereof by administering a composition having a protein transduction domain-MYC (PTD-MYC)…
Clinical Trial
Clinical Trial IDNCT03385486Start Date2018-05-01Completion Date2022-04-01PhasePhase 1Study TypeInterventionalStatusNot yet recruiting
This is a study of transfusion of TBX-3400 in patients with stage III and IV melanoma resistant or refractory to Immune Checkpoint Inhibitors. The patient's own blood cells are exposed to a protein that has been shown in the laboratory to result in anti-tumor activity. The study hypothesis is that TBX-3400 cells will enhance anti-tumor activity and improve the body's immune response.
Patent
Publication NumberEP 2966084 B1StatusIssued PatentAvailabilityUnknownFiling Date2009-08-28Publication Date2018-04-25
Disclosed herein are methods of modulation of the viability of a cell. Further disclosed herein are methods of modulating an immune response. Further disclosed herein are methods of identifying agents capable of modulation of the viability of a cell or an immune response. Further disclosed herein are agents and compositions capable of modulation of the viability of a cell or an immune response.
Patent
Publication NumberCN 105209604 BStatusIssued PatentAvailabilityUnknownFiling Date2014-03-11Publication Date2018-04-24
Disclosed are methods for manipulating and expanding stem cell populations, including adult stem cells, the cells produced by such methods, and various protein constructs related thereto.
Patent
Publication NumberCN 103937749 BStatusIssued PatentAvailabilityUnknownFiling Date2009-07-21Publication Date2018-04-17
Provided herein are methods for preparing differentiated cells, and the cells prepared by such methods.
We found 102 documents that match your Search
Research Grants: 8
Patents: 89
Clinical Trials: 2
SEC Filings: 3

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in